Herper, Matthew
January 2007
Forbes Asia;1/29/2007, Vol. 3 Issue 2, p53
This article profiles Genentech, selected as one of the best managed companies in the U.S. by the editors. In the past three years Genentech has launched three new drugs: the cancer treatment Avastin, Lucentis for macular degeneration and Tarceva, a pill for treating lung cancer. The company's biggest success last year came from the breast cancer medicine Herceptin, an old drug for which Chief Executive Arthur Levinson helped lay the groundwork as a Genentech research scientist 26 years ago.


Related Articles

  • In other business... Ukens, Carol // Drug Topics;9/2/96, Vol. 140 Issue 17, p96 

    Summarizes developments pertaining to companies in the pharmaceutical industry in the United States as of September 2, 1996. Includes acquisition of Lee's Pharmacy drugstore chain by PharmaSystems Cost Containment Corp.; Financial performance of Cardinal Health for the end of fiscal 1996;...

  • Scientific Methods. Rayasam, Renuka // U.S. News & World Report;2/19/2007, Vol. 142 Issue 6, p46 

    This article profiles Genentech, a successful biotech firm in San Francisco, California. Genentech is extremely profitable because they are successful at getting new drugs and therapies onto the market. In 2006, it received approval for eight new products. CEO Arthur Levinson is a researcher...

  • Business Watch 2002 IN REVIEW. Madden, Terri; Blankenhorn, Kathy; Duckwitz, Nancy // Medical Marketing & Media;May2001, Vol. 36 Issue 5, p74 

    Explores the sales performance and business condition of the pharmaceutical industry in the U.S. for 2000. Factors influencing the financial performance of the industry; Information on leading firms with their corresponding sales volume; Top five most frequently diagnosed conditions in the country.

  • New leadership position.  // Pharmaceutical Technology;Jan2005, Vol. 29 Issue 1, p100 

    The article informs that Wayne Constantin has joined Croda as eastern region sales manager and is now part of the team at the company's new North American headquarters and innovation center in Edison, New Jersey.

  • Hotlines.  // Adweek;5/8/2006, Vol. 47 Issue 19, p4 

    The article offers business news briefs from the United States. The executives of Roche Inc. are set to hear final presentations from five finalists, for its Tamiflu prescription drug account. Wyeth Laboratories Inc. has asked agencies to present ideas for an over-arching brand campaign and...

  • Millennium ends Takeda's US shopping spree. Sipp, Douglas // Nature Biotechnology;Jun2008, Vol. 26 Issue 6, p593 

    This article discusses Japan's Takeda Pharmaceutical's acquisition of Millennium Pharmaceuticals of Cambridge, Massachusetts. The purchase is one of several American companies bought by Japanese pharmaceutical companies. The Takeda deal is the largest acquisition of a foreign firm by the...

  • All Told.  // Pharmaceutical Executive;May2005, Vol. 25 Issue 5, p162 

    The article reports on the increase in marketing budget by pharmaceutical companies in the United States. In 2004, pharmaceutical companies spent more than ever before on promoting their products. In just one year spending grew by close to $5 billion. The largest portions of budgets were put...

  • Is bigger better? Clepper, Irene // Drug Topics;9/2/96, Vol. 140 Issue 17, p98 

    Focuses on mergers and acquisitions of pharmaceutical companies in the United States. Decline in number of wholesale drug manufacturers; Reasons for mergers; Customer consolidation; Purchase trends among wholesalers; Advantages and disadvantages of mergers for wholesalers.

  • US Pharmaceuticals In Transition for 2002. Krause, Carey // Chemical Market Reporter;1/7/2002, Vol. 261 Issue 1, p8 

    Deals with the prediction of analysts that the year 2002 will serve as a transition for major pharmaceutical companies in the United States to improve earnings in 2003. Earnings prediction of Morgan Stanley for the country's pharmaceutical sector; Key to the earnings improvement of companies in...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics